Directory
>
Mark Cobbold
Mark Cobbold
SVP, IO Discovery & Cell Therapy Oncology | AstraZeneca
Boston, Massachusetts, United States
Mark Cobbold
Summary
Mark Cobbold is a highly accomplished leader in the field of oncology, currently serving as the Senior Vice President of IO Discovery & Cell Therapy Oncology at AstraZeneca. With a robust background in immunology and biotechnology, he has co-founded several innovative companies, including Gritstone Oncology and Revitope, and has held significant academic positions at prestigious institutions like Harvard University. His expertise spans a wide range of topics, including cancer immunotherapy and drug discovery, making him a sought-after figure in the life sciences sector. Mark's career reflects a commitment to advancing cancer research through both academic and entrepreneurial endeavors. His work not only focuses on developing breakthrough therapies but also on mentoring the next generation of scientists. He is recognized for his contributions to the field and is passionate about translating research into impactful clinical solutions.
Mark Cobbold
Work Experience
SVP, IO Discovery & Cell Therapy Oncology at
AstraZeneca
March 2024 - Present
Scientific Co-Founder at
GigaMune
January 2019 - Present
Scientific co-founder at
Gritstone bio
October 2015 - Present
Scientific Founder at
Revitope
November 2014 - Present
VP Oncology Early Discovery at
AstraZeneca
September 2019 - March 2024
Associate Member at
The Broad Institute Inc
September 2015 - September 2019
Associate Professor of Medicine at
Harvard University
June 2015 - September 2019
Associate Professor at
Massachusetts General Hospital
June 2015 - September 2019
Scientific Co-Founder at
SERASCIENCE LIMITED
May 2011 - June 2015
Scientific Co-Founder at
PhosImmune Inc.
September 2012 - June 2015
Reader in Translational Immunology at
University of Birmingham Accommodation Services
March 2014 - May 2015
Senior Clinical Research Fellow (Tumour Immunology) at
University of Birmingham Accommodation Services
September 2009 - March 2014
MRC Clinician Scientist at
University of Birmingham Accommodation Services
January 2003 - January 2009
Visiting Clinical Research Fellow at
Rector & Visitors of The University of Virginia
January 2006 - December 2007
Mark Cobbold
Education
January 2000 - January 2003
Frequently Asked Questions about Mark Cobbold
What is Mark Cobbold email address?
Mark Cobbold's primary email address is ************@astrazeneca.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Cobbold work for?
Mark Cobbold is a SVP, IO Discovery & Cell Therapy Oncology at AstraZeneca, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Mark Cobbold graduated from?
Mark Cobbold holds a degree in Immunology / Immunotherapy from University of Birmingham.
How can I directly contact Mark Cobbold?
To contact Mark Cobbold directly, you can use the email address ************@astrazeneca.com. Complete contact information is available upon registration with Muraena.
Who is Mark Cobbold?
Mark Cobbold is a highly accomplished leader in the field of oncology, currently serving as the Senior Vice President of IO Discovery & Cell Therapy Oncology at AstraZeneca. With a robust background in immunology and biotechnology, he has co-founded several innovative companies, including Gritstone Oncology and Revitope, and has held significant academic positions at prestigious institutions like Harvard University. His expertise spans a wide range of topics, including cancer immunotherapy and drug discovery, making him a sought-after figure in the life sciences sector. Mark's career reflects a commitment to advancing cancer research through both academic and entrepreneurial endeavors. His work not only focuses on developing breakthrough therapies but also on mentoring the next generation of scientists. He is recognized for his contributions to the field and is passionate about translating research into impactful clinical solutions.
Mark`s contact details
************@astrazeneca.com
*********@bham.ac.uk
Colleagues
Chair
Vice President, Insights & Analytics
Advisory Board Member
Executive Board Member
Executive Medical Director / Global Product Leader - Early Development, Oncology R&D
President, Best Buy Health
GM Search International and Growth
Member Board Of Trustees
Chief Operating Officer - Oncology R&D
VP & Head, Neuroscience, BioPharma R&D, AstraZeneca